2026.02. 06 作者 | 一财阿驴 11:31 A股午盘丨创业板指半日涨0.65% 截至午盘，沪指涨0.11%，深成指涨0.65%，创业板指涨0.65%。科创综指涨0.51%。 盘面上，锂电池、能源金属、人形机器人、金融科技题材活跃，中药、化工板块涨幅靠前。白酒、零售、AI应用概念股走弱。 | 板块名称 | | 张幅� 张速 | | --- | --- | --- | | 草甘麟 | | +3.08% +0.07% | | 氟化工概念 | +3.08% | +0.16% | | 油气开采及服务 | +3.07% | +0.24% | | 染料 | +3.07% | +0.21% | | 环氧丙烷 | +2.94% | +0.14% | | PEEK材料 | +2.84% | +0.17% | | 磷化工 | +2.72% | +0.21% | | 丙烯酸 | +2.70% | +0.12% | | PVDF概念 | +2.61% | +0.11% | | 化学原料 | +2.60% | +0.15% | | 中药 | +2.52% | +0.06% | | 新型烟草(电子 ... | +2.51% | ...

Market Overview - The US labor market data has intensified market pessimism, leading to a systematic sell-off in the tech sector, which has quickly spread globally, putting pressure on risk assets and entering a clear "de-leveraging resonance" phase [1] - The three major indices opened lower but later rebounded, with the Shanghai Composite Index rising by 0.11%, the Shenzhen Component Index by 0.65%, and the ChiNext Index by 0.65% at midday [1] - The trading volume in the Shanghai and Shenzhen markets was 1.38 trillion yuan, a decrease of 63.3 billion yuan compared to the previous trading day [1] Geopolitical Impact - The situation in Iran remains tense, with the US State Department issuing a security warning for American citizens to leave Iran and prepare for self-reliant exit plans [2] - This geopolitical tension has led to a significant rebound in precious metals, with silver rising by 8% to $72.54 per ounce and gold increasing by over 1% to $4,826.9 per ounce [2] - International oil prices have also reversed course, with Brent crude rising from $66.9 to $67.5 [2] Sector Performance Chemical Sector - The chemical sector saw a broad rally, with stocks like Jinniu Chemical and Cangzhou Dahua hitting the daily limit [3][5] - The price of key intermediate materials for disperse dyes has surged from 25,000 yuan per ton to 38,000 yuan per ton, an increase of over 50% [5] Traditional Chinese Medicine - Stocks in the traditional Chinese medicine sector surged, with companies like Te Yi Pharmaceutical and Hansen Pharmaceutical hitting the daily limit [4] - The Ministry of Industry and Information Technology has issued a development plan for the traditional Chinese medicine industry, aiming for a collaborative development system by 2030 [4] Power Equipment - The power equipment sector, including transformers, showed strong performance with stocks like Jinkong Electric and Sanbian Technology hitting the daily limit [6][7] Precious Metals - The precious metals sector has rebounded, with stocks like Hunan Gold and Xianglu Tungsten hitting the daily limit [8] - Silver prices increased by over 2% during the day, while gold prices returned above $4,800 [8] Institutional Insights - CICC maintains a positive outlook on the Chinese stock market, noting that there are no typical bull market top signals, and the funding environment remains ample with improving performance [9][10] - Tianfeng Securities highlights that market sentiment is fragile, with any news changes potentially triggering concentrated sell-offs by short-term investors [11] - Huachuang Securities anticipates a strong recovery in the consumption market during the 2026 Spring Festival, driven by government-led initiatives and diverse promotional activities [12]

中国经济网北京2月6日讯 A股三大指数今日早盘探底回升全线翻红。截至午间收盘，上证指数报4080.31 点，涨幅0.11%；深证成指报14043.17点，涨幅0.65%；创业板指报3281.45点，涨幅0.65%。 (责任编辑：田云绯) A股市场板块涨跌幅排行 | 序号 | 板块 | 涨跌幅(%)▼ | | 总成交量（万手） = 总成交额（亿元）▼ | 净流入 (亿元) ▼ | 上涨家数 | 下跌家数 | | --- | --- | --- | --- | --- | --- | --- | --- | | 1 | 油气开采及服 | 3.07 | 1488.34 | 105.21 | 9.75 | 18 | റ | | | אר | | | | | | | | 2 | 化学原料 | 2.60 | 1199.21 | 120.25 | 17.96 | 57 | 2 | | 3 | 中药 | 2.52 | 1792.03 | 191.44 | -4.31 | 61 | 7 | | 4 | 电池 | 2.49 | 1109.02 | 434.76 | 72.95 | 92 | 11 | | 5 | 化学制品 | 2 ...

Market Overview - A-shares showed resilience against external market pressures, with major indices recovering after a low opening, resulting in the Shanghai Composite Index rising by 4.40 points (0.11%) to 4080.31 points, the Shenzhen Component Index increasing by 90.46 points (0.65%) to 14043.17 points, and the ChiNext Index up by 21.17 points (0.65%) to 3281.45 points [1] Sector Performance - The chemical sector saw strong performance, with stocks like Cangzhou Dahua, Jinniu Chemical, Baichuan Co., and Baihehua hitting the daily limit [1] - The humanoid robot concept stocks were active, with companies such as Wuzhou Xinchun, Liancheng Precision, and Tianqi Co. also reaching the daily limit [1] - The non-ferrous metals sector showed signs of recovery, with Hunan Gold and Xianglu Tungsten hitting the daily limit [1] - The traditional Chinese medicine sector opened strong, with stocks like Te Yi Pharmaceutical reaching the daily limit [1] Policy Support - The Chinese government, through the Ministry of Industry and Information Technology and other departments, issued a development plan for the traditional Chinese medicine industry, aiming for a collaborative development system by 2030, which is expected to boost the sector's growth [2] Price Dynamics - The price of disperse dyes surged due to a significant increase in the cost of upstream key intermediates, rising from 25,000 yuan/ton to 38,000 yuan/ton, a more than 50% increase, which is expected to drive up prices in the textile dyeing industry as demand increases post-Spring Festival [3] Market Challenges - The liquor sector faced downward pressure, with stocks like Huangtai Liquor hitting the daily limit down, attributed to a decline in demand following the consumption peak around the Spring Festival and increased competition leading to price cuts [4] - AI application stocks experienced declines, with companies like Yaowang Technology and Zhejiang Wenhu falling to the daily limit due to concerns over technology maturity and unclear business models [5] - The optical module and CPO sectors continued to adjust, with stocks like Yuanjie Technology and Xinyisheng dropping over 6% as market expectations normalized [6] Institutional Insights - Zhongjin Securities noted that despite external pressures, there are no typical bull market top signals in Chinese stocks, with ample liquidity and improving earnings, suggesting a continued positive outlook for Chinese asset revaluation [7] - Tianfeng Securities highlighted the fragility of market sentiment, indicating that any news could trigger short-term sell-offs, particularly in the gold market [7] - Huachuang Securities observed a strong recovery in consumer markets expected for the 2026 Spring Festival, driven by government-led consumption initiatives, suggesting potential growth in sectors like dining, tourism, and retail [7]

每经记者｜黄胜 每经编辑｜金冥羽 记者|黄胜 编辑|金冥羽 杜波 校对|许绍航 2月6日，三大指数探底回升全线翻红，创业板指早盘一度跌近2%。超4000只个股上涨，锂电、中药、化工、电网、油气等方向涨幅居前。 | Wind热门概念指数 | | | | | --- | --- | --- | --- | | 伊电电 化学纤 磷化工 氟化工 化学原 维生素 特高压 细矿 | | | 动力电 | | 5.38% 3.70% 3.43% 3.16% 3.12% 2.94% 2.86% 2.78% 2.76% | | | | | 伊电正 | 钢离子 固态电 锂电池 钾电负 铝产业 PEEK材 小金属 磷酸铁 | | | | 2.71% 2.58% 2.57% 2.54% 2.52% 2.45% 2.45% 2.42% 2.44% | | | | | 黄金珠 化学制 光通信 字树机 电池回 宁德时 西藏振 开线充 | | | 中级 | | 2.38% 2.35% 2.24% 2.26% 2.19% 2.18% 2.14% 2.14% | | | 2.09% | | 储能 稀有金 高速铜 航运 首发经 腾讯平 Kimi | ...

Core Viewpoint - The stock of Te Yi Pharmaceutical (002728) reached a limit-up of 13.15 yuan following the announcement of a new development plan for the traditional Chinese medicine industry by multiple government departments [1] Industry Summary - On February 5, eight government departments, including the Ministry of Industry and Information Technology, the State-owned Assets Supervision and Administration Commission, and the Financial Regulatory Bureau, jointly issued the "Implementation Plan for High-Quality Development of the Traditional Chinese Medicine Industry (2026-2030)" [1] - The plan outlines development goals, key tasks, and support measures for the traditional Chinese medicine industry over the next five years, aiming to promote a comprehensive upgrade of the entire industry chain [1]

Group 1 - The Chinese medicine (core stocks) sector experienced a significant rise, with notable increases in stock prices for companies such as Zhendong Pharmaceutical (+19.16%) and Shengwugu (+13.86%) [1][2] - The Ministry of Industry and Information Technology and seven other departments recently issued the "Implementation Plan for the High-Quality Development of the Chinese Medicine (Core Stocks) Industry (2026-2030)", aiming to establish a collaborative development system for the entire industry chain by 2030 [2][3] Group 2 - The plan outlines six major actions, including improving raw material quality and supply, enhancing manufacturing capabilities, and promoting the revitalization of the national medicine industry, with 15 specific tasks to be implemented [3] - The initiative aims to cultivate 60 high-standard Chinese medicine raw material production bases and support the establishment of 10 major traditional Chinese medicine varieties, while also promoting innovation in Chinese medicine products [3][4] Group 3 - Companies involved in the planting and processing of Chinese medicinal materials are expected to benefit from the establishment of high-standard production bases and the development of modern seed industries, leading to standardized and large-scale growth opportunities [4] - Firms focusing on innovative research and development in Chinese medicine will gain from the encouragement of AI and big data technologies, which will facilitate the transformation of classic formulas into innovative drugs [4][5] Group 4 - The plan includes the construction of 20 smart factories and 10 green factories, which will enhance production efficiency and product quality through digital transformation [4][5] - Companies like Te Yi Pharmaceutical and Hongri Pharmaceutical are positioned to benefit from the promotion of traditional Chinese medicine products and the digitalization of manufacturing processes, respectively [6]

港股 中药股盘初强势，其中，中国中药一度涨超8%，目前回落至3%，位元堂涨5.8%， 同仁堂国药、 福森药业涨超1%， 白云山、同仁堂科技、吉林长龙药业跟涨。 ...

Core Insights - The Hong Kong Traditional Chinese Medicine (TCM) stocks showed strong performance, with China Traditional Chinese Medicine rising over 8% initially before settling at a 2.9% increase, while other stocks like Wei Yuan Tang and Tong Ren Tang Guo Yao also saw gains [1][2] Industry Developments - The Ministry of Industry and Information Technology, along with eight other departments, issued the "Implementation Plan for High-Quality Development of the TCM Industry (2026-2030)" [1] - By 2030, a collaborative development system for the entire TCM industry chain is expected to be initially formed, with enhanced stable supply capabilities for key TCM raw materials and significant improvements in digitalization and greening levels [1] - The plan emphasizes the use of artificial intelligence and big data to create knowledge graphs for classic formulas and experiences from renowned TCM practitioners [1] Policy Implications - Analysts view this plan as a systemic, long-term policy benefit for TCM stocks, marking a shift from "extensive growth" to "quality and value-driven" development [1] - The plan serves as a "general program" for the development of the TCM industry over the next five years, focusing on raising industry standards, encouraging innovation, and driving a profound supply-side reform [1]

Group 1 - The core viewpoint of the news is that the Chinese traditional medicine sector is experiencing a strong market response following the release of a new development plan by the Ministry of Industry and Information Technology and seven other departments, which aims to enhance the quality and innovation of the industry by 2030 [1] - The plan outlines that by 2030, a collaborative development system for the entire traditional Chinese medicine (TCM) industry chain will be initially formed, with a focus on stable supply of key TCM raw materials and significant improvements in digitalization and greening levels [1] - Analysts suggest that this plan represents a systematic and long-term policy benefit for TCM stocks, marking a shift from "extensive growth" to "quality and value-driven" growth, serving as a guiding framework for the development of the TCM industry over the next five years [1] Group 2 - The stock performance of TCM companies shows a positive trend, with China Traditional Chinese Medicine rising over 8% at one point, currently up by 2.9%, and other companies like Yuyuan Tang and Tong Ren Tang also experiencing gains [2] - Specific stock price changes include: Yuyuan Tang at 0.365 with a 5.80% increase, China Traditional Chinese Medicine at 2.130 with a 2.90% increase, and Fosen Pharmaceutical at 0.750 with a 1.35% increase [2] - Other companies such as Tong Ren Rong Guo Yao, Baiyun Mountain, Tong Ren Tang Technology, and Jilin Changlong Pharmaceutical also reported slight increases in their stock prices, indicating a broader positive sentiment in the TCM sector [2]